Yusuf Qamruzzaman, MD
Hematology & Oncology Physician · Royal Oak, MI
Yusuf Qamruzzaman, MD is a hematology & oncology physician with a practice address in Royal Oak, Michigan, and NPI 1174738231, issued on May 11, 2007. Check the license (Michigan 4301104226, as entered in NPPES) on the Michigan Board of Medicine (LARA); the Medicare figures below come from public CMS files.
- Name
- Yusuf Qamruzzaman
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- 4301104226 MI
Self-reported in NPPES; status is on the state search - Practice location
- 3577 W 13 Mile Road Ste 103, Royal Oak, MI 48073
- Phone
- (313) 274-1800
- Enumerated
- May 11, 2007
- Record last updated
- Apr 12, 2022
- Fax
- (313) 769-6285
- Medicare enrollment
- Enrolled (PECOS I20131217000110); accepts Medicare assignment
- Medical or professional school
- Wayne State University School Of Medicine, 2007
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 340 in Michigan → Look up another NPI →
Verify Yusuf Qamruzzaman in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMichigan Board of Medicine (LARA)
Search for license 4301104226Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
23% more Medicare Part D claims than the average hematology & oncology physician in 2024
1,080 Medicare Part D claims for 212 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 26% of claims. 34 claims were for opioids.
Most prescribed
- Letrozole110 claims
- Eliquis81 claims
- Prochlorperazine Maleate57 claims
- Prednisone47 claims
- Abiraterone Acetate45 claims
- Anastrozole44 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $777.47
40 payments; by number, the most common kind was food and beverage; the largest payer was Novartis Pharmaceuticals Corporation. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Michigan Healthcare Professionals PCFarmington Hills, MI
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Yusuf Qamruzzaman among 340 hematology & oncology physician records in Michigan
Yusuf Qamruzzaman, MD is one of 340 hematology & oncology physician records with a practice address in Michigan. 82% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 41% of them.
- NPI issued2007 · 41% of these records are older, 47% newer
- In a Medicare fileYes · 82% of these records are
- In the CMS Doctors and Clinicians fileYes · 61% of these records are
- Graduated2007 · median 2004 among the 206 with a school on file
- Record last updated2022 · 52% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Michigan practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Michigan
There are 340 hematology & oncology physician records in Michigan.
All 340 in Michigan → Every provider in Royal Oak → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Samer Ballouz, M.D.Royal Oak, MI 480731528068020
- Janet Chapman, M.D.Royal Oak, MI 480731972723385
- Matthew Cotant, M.D.Royal Oak, MI 480731003930215
- Marianne Huben, D.O.Royal Oak, MI 480731871552414
- Mohammed Ibrahim, MDRoyal Oak, MI 480731891701082
- Deepa Jagtap, M.D.Royal Oak, MI 480731629190095
- Ishmael Jaiyesimi, D.O.Royal Oak, MI 480731538128178
- Manolo Magno, M.D.Royal Oak, MI 480731659371151
Common questions
What is Yusuf Qamruzzaman, MD's NPI number?
Yusuf Qamruzzaman, MD's National Provider Identifier (NPI) is 1174738231, issued on May 11, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Yusuf Qamruzzaman, MD located?
The NPPES record lists a practice address at 3577 W 13 Mile Road Ste 103, Royal Oak, MI, 48073. Phone: (313) 274-1800. Providers update this record themselves, so call before visiting.
How can I verify Yusuf Qamruzzaman, MD's license?
NPPES lists Michigan license number 4301104226, as entered by the provider. Search the Michigan Board of Medicine (LARA) at https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?isLicensee=Y&TabName=APO. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Yusuf Qamruzzaman, MD prescribe under Medicare Part D?
In 2024, Yusuf Qamruzzaman, MD had 1,080 Medicare Part D claims for 212 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.